A detailed history of Salem Capital Management Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Salem Capital Management Inc holds 2,897 shares of LLY stock, worth $2.31 Million. This represents 0.74% of its overall portfolio holdings.

Number of Shares
2,897
Previous 2,897 -0.0%
Holding current value
$2.31 Million
Previous $939,000 0.21%
% of portfolio
0.74%
Previous 0.68%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 27, 2022

SELL
$278.73 - $327.27 $110,655 - $129,926
-397 Reduced 12.05%
2,897 $939,000
Q4 2021

Jan 18, 2022

BUY
$224.85 - $279.04 $22,485 - $27,904
100 Added 3.13%
3,294 $910,000
Q3 2021

Oct 12, 2021

SELL
$221.6 - $272.71 $66,480 - $81,813
-300 Reduced 8.59%
3,194 $738,000
Q2 2021

Jul 13, 2021

SELL
$180.55 - $233.54 $144,440 - $186,832
-800 Reduced 18.63%
3,494 $802,000
Q1 2021

Apr 15, 2021

SELL
$164.32 - $212.72 $8,216 - $10,636
-50 Reduced 1.15%
4,294 $802,000
Q3 2020

Oct 13, 2020

SELL
$146.22 - $169.13 $73,110 - $84,565
-500 Reduced 10.32%
4,344 $643,000
Q3 2019

Oct 07, 2019

SELL
$106.79 - $116.16 $21,037 - $22,883
-197 Reduced 3.91%
4,844 $542,000
Q2 2019

Jul 09, 2019

SELL
$110.79 - $129.32 $57,278 - $66,858
-517 Reduced 9.3%
5,041 $558,000
Q1 2019

Apr 15, 2019

BUY
$111.31 - $131.02 $44,190 - $52,014
397 Added 7.69%
5,558 $721,000
Q4 2018

Jan 08, 2019

SELL
$105.9 - $118.64 $24,568 - $27,524
-232 Reduced 4.3%
5,161 $597,000
Q3 2018

Oct 09, 2018

SELL
$85.86 - $107.31 $14,939 - $18,671
-174 Reduced 3.13%
5,393 $579,000
Q4 2017

Jan 16, 2018

SELL
$81.94 - $87.89 $40,970 - $43,945
-500 Reduced 8.24%
5,567 $470,000
Q3 2017

Oct 10, 2017

BUY
$77.07 - $85.54 $467,583 - $518,971
6,067
6,067 $519,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Salem Capital Management Inc Portfolio

Follow Salem Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Salem Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Salem Capital Management Inc with notifications on news.